Compile Data Set for Download or QSAR
maximum 50k data
Found 211 with Last Name = 'jantos' and Initial = 'k'
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316365(US9617226, Example 46 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  1nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175056(US9688678, 18 (+-)3-(2-methoxyphenyl)-1-[(5-methox...)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM174904(US9688678, 1A (+)-3-(2-ethoxy-5-methoxy-phenyl)-1-...)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175037(US9688678, 9A (+)-3-(2-ethoxy-3-pyridyl)-1-[(5-met...)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175039(US9688678, 11 (+)-3-(2-ethoxy-5-methoxyphenyl)-1-(...)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175054(US9688678, 17 (+-)-3-(2-ethoxy-5-methoxy-phenyl)-1...)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175055(US9688678, 17B (+)-3-(2-ethoxy-5-methoxy-phenyl)-1...)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316345( cis-N-tert-Butyl-2-[2-(3-chlorophenyl)-4-oxo-6-[3...)
Affinity DataKi: <1nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175057(US9688678, 18A (+)-3-(2-methoxyphenyl)-1-[(5-metho...)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175058(US9688678, 19 (+-)-3-(2-ethoxy-5-methoxy-phenyl)-3...)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175060(US9688678, 21 (+-)-3-(2,5-dimethoxyphenyl)-1-[(5-m...)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175064(US9688678, 25 (+)-3-(2-ethoxy-5-methoxy-phenyl)-1-...)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175212(US9688678, 34 (3S)-1-[(5-chloro-2-pyridyl)sulfonyl...)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316327(US9617226, Example 8 | cis-2-[2-(3-Chlorophenyl)-4...)
Affinity DataKi: <1nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Abbvie Deutschland

Curated by ChEMBL
LigandPNGBDBM50258318(CHEMBL4066494)
Affinity DataKi:  1.80nMAssay Description:Inhibition of human procathepsin K expressed in Escherichia coli using Z-Gly-Pro-Arg-AMC as substrate by kinetic fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316349(US9617226, Example 30 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316344(US9617226, Example 25 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316352( cis-2-[2-(3-Chlorophenyl)-6-[3-[[(3R)-3-hydroxy-1...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316353(US9617226, Example 34 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316355(US9617226, Example 36 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316356( cis-2-[2-(3-Chlorophenyl)-6-[3-[ [(3S)-3-hydroxy-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316357(US9617226, Example 38 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316358(US9617226, Example 39 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316359(US9617226, Example 40 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316360(US9617226, Example 41 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316361( cis-2-[2-(3-Chlorophenyl)-6-[3-[[(2S,6R)-2,6-dime...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316363(US9617226, Example 44 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316364( cis-2-[2-(3-Chlorophenyl)-4-oxo-6-[3-(1-piperidyl...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM174900(US9688678, 1 (+-)-3-(2-ethoxy-5-methoxy-phenyl)-1-...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175032(US9688678, 5 (+-)-3-(2-ethoxy-5-methoxy-phenyl)-1-...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175034(US9688678, 7 (+-)-3-(2-ethoxy-4-fluoro-phenyl)-1-[...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175035(US9688678, 8 (+-)-3-(2-ethoxyphenyl)-1-[(5-methoxy...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175036(US9688678, 9 (+-)-3-(2-ethoxy-3-pyridyl)-1-[(5-met...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175038(US9688678, 10 (+-)-3-(2-ethoxy-5-methoxy-phenyl)-1...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175059(US9688678, 20 (+-)-3-(2-ethoxy-5-methoxy-phenyl)-3...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175061(US9688678, 22 (+-)-3-(2-methoxy-3-pyridyl)-1-[(5-m...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175062(US9688678, 23 (+)-3-(2-methoxyphenyl)-1-[(5-methox...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175065(US9688678, 26 (+-)-3-(2-methoxyphenyl)-1-[(5-metho...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175066(US9688678, 27 (+-)-3-(2-ethoxy-3-pyridyl)-1-[(5-me...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175067(US9688678, 28 (+-)-3-(2-ethoxy-5-methoxy-phenyl)-1...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175068(US9688678, 29 (+-)-3-(2-ethoxy-5-methoxy-phenyl)-1...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175069(US9688678, 30 (+-)-3-[2-(1,1-difluoroethyl)-3-pyri...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175074(US9688678, 31 (3S)-3-(2-ethoxy-5-methoxy-phenyl)-1...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175211(US9688678, 33 (3S)-3-(2-ethoxy-5-methoxy-phenyl)-3...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316322(US9617226, Example 2a | cis-2-[2-(3-chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316329(US9617226, Example 10 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316328(US9617226, Example 11 | US9617226, Example 9 | cis...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316331(US9617226, Example 12 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316332(US9617226, Example 13 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316333(US9617226, Example 14 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 211 total ) | Next | Last >>
Jump to: